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Posttranslational modification of cell-cycle regula-
tors with ubiquitin chains is essential for eukaryotic
cell division. Such chains can be connected through
seven lysine residues or the amino terminus of
ubiquitin, thereby allowing the assembly of eight
homogenous and multiple mixed or branched conju-
gates. Although functions of homogenous chain
types have been described, physiological roles of
branched structures are unknown. Here, we report
that the anaphase-promoting complex (APC/C)
efficiently synthesizes branched conjugates that
contain multiple blocks of K11-linked chains. Com-
pared to homogenous chains, the branched conju-
gates assembled by the APC/C strongly enhance
substrate recognition by the proteasome, thereby
driving degradation of cell-cycle regulators during
early mitosis. Our work, therefore, identifies an
enzyme and substrates for modification with
branched ubiquitin chains and points to an important
role of these conjugates in providing an improved
signal for proteasomal degradation.
INTRODUCTION
Ubiquitylation controls critical signaling pathways in eukaryotes
and is essential for cell proliferation, differentiation, and survival
(Deshaies and Joazeiro, 2009; Schulman and Harper, 2009). The
transfer of a single ubiquitin to a substrate, a reaction referred to
as monoubiquitylation, typically alters interactions, localization,
or activity of the modified protein (Dikic et al., 2009). Conversely,
the attachment of multiple ubiquitin molecules results in poly-
meric chains that, depending on their connectivity, could have
unique functions.
Ubiquitin chain formation can occur through seven lysine
residues or the amino terminus of ubiquitin, leading to the
assembly of multiple chains with distinct topology (Komander
and Rape, 2012). All linkages have been detected in cells, and
their abundance changes during cell division or differentiation
(Peng et al., 2003; Xu et al., 2009). The first chain types to be
discovered, termed canonical ubiquitin chains, had distinct con-910 Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc.sequences for the modified protein: whereas chains connected
through K48 of ubiquitin promoted proteasomal degradation,
K63-linked chains regulated the assembly of oligomeric com-
plexes (Chau et al., 1989; Johnson et al., 1995; Spence et al.,
2000; Wang et al., 2001). Based on these observations, it was
hypothesized that many ubiquitylation marks might trigger
unique biological outcomes, reminiscent of a code.
Yet as roles of atypical conjugates are only beginning to
emerge, the complexity of ubiquitin-dependent signaling
remains poorly understood. In addition to the canonical conju-
gates, homogenous chains could also be formed bymodification
of M1, K6, K11, K27, K29, or K33 (Jin et al., 2008; Tokunaga
et al., 2009). Several of these linkages can mediate proteasomal
degradation, but the reason for this redundancy is unclear (Jin
et al., 2008; Johnson et al., 1995; Koegl et al., 1999; Xu et al.,
2009). Conjugates of more complex topology, such as mixed
chains, are formed during endocytosis or immune signaling
(Boname et al., 2010; Emmerich et al., 2013). Proteomic analyses
also showed that a single ubiquitin molecule embedded within
a chain can be modified at two or more sites, a process that
leads to the assembly of branched conjugates (Kim et al.,
2007; Peng et al., 2003). In vitro, branched linkages through
K27, K29, or K33 of ubiquitin impede proteasomal recognition
(Kim et al., 2007). However, as neither physiological enzymes
nor substrates are known, it remains unclear whether
branched conjugates play important roles in ubiquitin-depen-
dent signaling.
The anaphase-promoting complex (APC/C) provides a power-
ful model to test for functions of atypical chains. Whereas yeast
APC/C modifies its substrates with canonical K48-linked chains
(Rodrigo-Brenni and Morgan, 2007), the metazoan APC/C as-
sembles atypical K11-linked conjugates to drive proteasomal
degradation and mitotic exit (Jin et al., 2008; Matsumoto et al.,
2010). In human cells, the APC/C initiates chain formation by
using the E2 Ube2C (also known as UbcH10, UbcX, Vihar, or
E2C). Although Ube2C prefers to synthesize K11 linkages, it
also connects ubiquitin molecules through K48 or K63 (Kirkpa-
trick et al., 2006; Williamson et al., 2011). Another APC/C-E2,
Ube2S, recognizes substrate-attached ubiquitin to produce spe-
cific K11-linked chains (Wickliffe et al., 2011; Williamson et al.,
2009; Wu et al., 2010). The abundance of K11 linkages rises
dramatically during mitosis, when the APC/C is active, and this
boost in K11-linked chain formation is dependent on Ube2S
(Matsumoto et al., 2010; Wickliffe et al., 2011). However, as
substrates that require Ube2S for degradation have not been
reported, the physiological importance of K11-linked chains
has not been fully addressed.
In this study, we have identified APC/C substrates, including
the kinase Nek2A, that require Ube2S for degradation. The
reconstitution of Nek2A-ubiquitylation revealed that Ube2S
does not simply extend a conjugate but instead branches multi-
ple K11-linked chains off the assemblies produced by Ube2C.
Compared to homogenous chains, branched conjugates syn-
thesized by the APC/C increase the efficiency of proteasomal
substrate recognition and, accordingly, are required for the
degradation of cell-cycle regulators at times of limited APC/C
activity. Our work identifies the APC/C as an enzyme that synthe-
sizes branched ubiquitin chains and ascribes an important role to
these conjugates in providing an improved signal for proteaso-
mal degradation.
RESULTS
Prometaphase APC/C Substrates Require Ube2S
for Degradation
The metazoan APC/C cooperates with Ube2S to assemble K11-
linked chains that drive the degradation of cell-cycle regulators
during mitosis and G1. However, as depletion of Ube2S showed
few defects during mitosis, it is not fully understood whether
K11-linked chains have essential roles for cell division (Garnett
et al., 2009; Williamson et al., 2009; Wu et al., 2010). To address
this issue, we systematically screened cells that expressed
Ube2S at less than 2% of their normal abundance for changes
in protein levels. Strikingly, depletion of Ube2S caused a strong
increase in the abundance of Nek2A kinase during prometa-
phase, a cell-cycle stage when the APC/C is partially inhibited
by the spindle checkpoint (Figure 1A; Figure S1A available
online). The accumulation of Nek2A was seen with multiple small
interfering RNAs (siRNAs) against Ube2S and reversed by stable
expression of siRNA-resistant Ube2S (Figures 1A and S1B).
Depletion of Ube2S neither changed the levels of Nek2A
mRNA nor the mitotic stage of synchronized cells, suggesting
that it instead affected the stability of the Nek2A protein (Figures
S1C and S1D).
Based on these findings, we tested by cycloheximide chase
experiments whether Ube2S was required for APC/C substrate
degradation during prometaphase. Indeed, the depletion of
Ube2S resulted in a pronounced increase in the half-life of
Nek2A and of the CDK-inhibitor p21, another APC/C substrate
(Figure 1B). Accordingly, purification of ubiquitin conjugates
from prometaphase cells revealed that Ube2S was required for
the attachment of high molecular weight (MW) chains to endog-
enous Nek2A and p21 (Figures 1C and S1E). Ube2S also medi-
ated the ubiquitylation of Cdc20 (Figures 1B and 1C), a reaction
that disassembles spindle checkpoint complexes (Foster and
Morgan, 2012; Reddy et al., 2007; Uzunova et al., 2012; William-
son et al., 2009). By contrast, another prometaphase substrate,
cyclin A, was not stabilized (Figure S1A), which might be due to
incomplete Ube2S depletion or redundant mechanisms govern-
ing degradation of this cell-cycle regulator (Kikuchi et al., 2013).
In agreement with our results, the loss of Ube2S had pronounced
effects on early mitosis: it delayed sister chromatid separation,blocked release of cells from a spindle checkpoint-induced ar-
rest, and sensitized cells to low concentrations of nocodazole
(Figures 1D, 1E, and S1F). These experiments, therefore, show
that Ube2S is important during prometaphase, a cell-cycle
time when the spindle checkpoint reduces overall APC/C
activity.
The APC/C Synthesizes Branched Ubiquitin Chains
In Vitro
To dissect the role of Ube2S during prometaphase, we reconsti-
tuted the ubiquitylation of Nek2A. Previous work has shown that
Ube2S elongates K11-linked chains that have been initiated by
Ube2C or Ube2D (Garnett et al., 2009; Williamson et al., 2009;
Wu et al., 2010). In agreement with this model, the APC/C and
its E2smodified Nek2Awith highMWconjugates in the presence
of wild-type, but not a K11R mutant of ubiquitin (ubiR11; Figures
2A and S2A). Chains derived with ubiR11, which cannot be used
by Ube2S for chain formation, closely mirrored those seen in
cells lacking Ube2S, showing that our reconstitution recapitu-
lated the in vivo modification of Nek2A. Surprisingly, the MW of
Nek2A conjugates was strongly reduced in reactions that con-
tained a ubiquitin mutant with K11 as the only site for chain
formation (ubiK11; Figures 2A and S2A). This was in contrast to
substrates modified by Ube2S alone (Figure 2B) and suggested
that formation of high MW chains on Nek2A was dependent on
multiple linkages.
Conjugates with multiple linkages could be mixed chains, in
which distinct connections are used within a single conjugate,
or branched structures, in which at least one moiety received
two or more ubiquitin molecules. To distinguish between these
possibilities, we incubated Nek2A with mixtures of ubiR11 and
ubiK11. If the APC/C assembled mixed chains, it could sequen-
tially use ubiR11 and ubiK11 to build conjugates of similar MW
as seen with ubiquitin. In contrast, branched conjugates that
result from concurrent modification of K11 and another ubiquitin
lysine could not be assembled; thus, if the APC/Cwere a branch-
ing enzyme, chains formed with ubiK11 and ubiR11 should be of
lower MW than those with WT-ubiquitin. Importantly, Nek2A
was modified with low MW conjugates in the presence of
ubiR11 and ubiK11, suggesting that the APC/C decorated this
substrate with branched chains (Figures 2A and S2A).
As physiological enzymes for the assembly of branched
chains are unknown, we wished to test the notion that the
APC/C could produce such conjugates. To this end, we circum-
vented the initiation step and incubated APC/C and Ube2S with
substrates already linked to linear chains of defined length. We
investigated two prometaphase APC/C substrates: Nek2A,
which requires Ube2S for degradation, and cyclin A, which can
be robustly ubiquitylated in vitro (Rape et al., 2006). We supple-
mented these reactions withmethylubiquitin, which allows trans-
fer of the first ubiquitin by Ube2S but interferes with further chain
extension. If Ube2S elongates pre-existing chains, only the distal
ubiquitin of our substrates should bemodified, yet if it assembles
branched conjugates, internal moieties could be ubiquitylated as
well. Demonstrating the formation of branched chains, Ube2S
added two methylubiquitin molecules to Ub-Ub-cyclin A, and it
attached one ubiquitin to a substrate variant that lacked Lys11
in its distal moiety (UbR11-Ub-cyclin A; Figure 2C).Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc. 911
Figure 1. Ube2S Is Required for APC/C Substrate Ubiquitylation in Prometaphase
(A) Ube2S was depleted from prometaphase HeLa cells resistant to hygromycin (HeLa-HR) or stably expressing siRNA-resistant Ube2S and analyzed for Nek2A
levels by western blot.
(B) HeLa cells transfectedwith control or Ube2S siRNAswere synchronized in prometaphase, treatedwith cycloheximide, and analyzed for protein abundance by
western blot.
(C) HeLa cells expressing Hisubiquitin and transfected with control or Ube2S siRNA were synchronized in prometaphase and treated with MG132. Purified
ubiquitin conjugates were analyzed by aNek2A- or aCdc20-western blot.
(D) Nocodazole-arrestedHeLa cells treatedwith control or Ube2S siRNAswere released into drug-freemedium, and protein levels were analyzed bywestern blot.
(E) Depletion of Ube2S delays anaphase initiation. HeLa cells stably expressing GFPtubulin and mCherryhistone H2B were transfected with control or Ube2S siRNA
and monitored by live-cell imaging. The time from nuclear envelope breakdown to initiation of sister chromatid separation was determined for >130 cells per
condition.
See also Figure S1.Ube2S synthesized the branched linkage on UbR11-Ub-cyclin
A with the same specificity and efficiency as seen for elongation
(Figures 2D and S2B), and it branched ubiquitin molecules off
substrates with longer chains, such as Ub3-cyclin A and Ub3-
Nek2A (Figures 2D and 2E). If these assays were performed
with WT-ubiquitin, Ube2S branched a block of 6 K11-linked
molecules off each ubiquitin containing a free K11, thereby effec-
tively modifying Ub-Ub-cyclin A with chains that had twice the
MW as those on Ub-cyclin A or UbR11-Ub-cyclin A (Figure 2C).
Ube2S acts after Ube2C, which decorates APC/C substrates
with short chains containing 50% K11 linkages, but also K48
and K63 linkages (Kirkpatrick et al., 2006). If Ube2C produced912 Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc.the latter two linkages, Ube2S could use an internal ubiquitin to
branch off a K11-linked chain. To test this hypothesis, we incu-
bated Ub-cyclin A with Ube2C at concentrations that led to the
formation of short chains (Ub3-cyclin A).We stopped the initiation
stepwith an excess of Ube2CC114S, which does not affect Ube2S
(Wickliffe et al., 2011), and then added methylubiquitin and
Ube2S. Again demonstrating the assembly of branched conju-
gates, Ube2S attached up to three ubiquitin molecules to Ub3-
cyclin A produced by Ube2C (Figure S2C). In addition, we
performed single-substrate turnover reactions with ubiR48/63 or
ubiK6/K11. These mutants support formation of K11-linked chains
but prevent the synthesis of K48 and K63 linkages by Ube2C that
Figure 2. The APC/C Assembles Branched Ubiquitin Chains
(A) Nek2A is modified with branched chains in vitro. 35S-labeled Nek2A272-445 was incubated with APC/CCdc20, Ube2C, Ube2S, and ubiquitin mutants. Reactions
were analyzed by autoradiography.
(B) 35S-labeled Ub-cyclin A was incubated with APC/CCdc20, Ube2S, and ubiquitin mutants. Reactions were analyzed by autoradiography.
(C) Ub-cyclin A, UbR11-cyclinA, Ub-Ub-cyclin A, and UbR11-Ub-cyclin A were incubated with APC/C, Ube2S, and methylubiquitin or ubiquitin. Left: reaction
products if Ube2S would elongate or branch chains (pink: fused substrate-ubiquitin; red: ubiquitin added by Ube2S). Right: reactions were analyzed by
aHA-western.
(D) Ub-cyclin AHA, Ub-Ub-cyclin AHA, or Ub-Ub-Ub-cyclin AHA was incubated with APC/CCdh1, Ube2S, and methylubiquitin or ubiR11. Reaction products were
analyzed by aHA-western blot. Red dot, first added ubiquitin; blue dot, second added ubiquitin; green dot, third added ubiquitin.
(E) Ube2S efficiently modifies Nek2Awith branched chains in vitro. Ub3-Nek2Awas incubated with APC/C, Ube2S, andmethylubiquitin or ubi
R11 and analyzed by
aNek2A-western blot. Nek2A was used as control (left).
See also Figure S2.are required for branching by Ube2S. Importantly, Ube2S deco-
rated APC/C substrates with high MW chains in the presence of
Ube2C and WT-ubiquitin, but not if Ube2C was omitted or
ubiR48/63 or ubiK6/K11 was used (Figures S2D and S2E). Thus,
the APC/C modifies substrates with branched chains in vitro.
The APC/C Synthesizes Branched Ubiquitin Chains
in Cells
As seen by mass spectrometry, the APC/C decorated Nek2A
with chains containing K11, K48, and K63 linkages (Figure S3A).
Based on the linkage specificities of Ube2C and Ube2S (Kirkpa-
trick et al., 2006; Williamson et al., 2009), this finding implied that
Ube2S assembles K11/K48 and K11/K63 branches, which—
because of the multiple Lys and Arg residues separating the
two attachment sites in the branched ubiquitin—cannot bedetected by trypsin-based mass spectrometry. We, therefore,
developed an alternative method to monitor formation of
branched chains that allowed us to follow the synthesis of
such conjugates in cells (Figure 3A): we identified two ubiquitin
residues, Gly53 and Glu64, that permitted insertion of a TEV-
cleavage site and FLAG-epitope and were still recognized by
Ube2S and APC/C (Figures 3B, 3C, and S3B). We modified sub-
strates with ubi53TEV and ubi64TEV/FLAG and then treated the reac-
tion products with TEV protease. This led to the collapse of long
chains and the emergence of diagnostic FLAG-reactive pep-
tides: although modification of a distal moiety produced a small
FLAG-reactive cleavage product, branches could be seen as
additional species of higher MW. We had to use both ubi53TEV
and ubi64TEV/FLAG, as this mixture proved to be most efficient in
competing with WT-ubiquitin in later in vivo experiments.Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc. 913
Figure 3. The APC/C Assembles Branched Chains in Cells
(A) Outline of amethod tomonitor synthesis of branched chains. A TEV site and FLAG-epitope (ubiTEV/FLAG) were introduced into ubiquitin. Cleavage of ubiTEV/FLAG
conjugates reveals an 2 kDa stamp for elongation or multiple stamps for branching.
(B) ubiTEV/FLAG is recognized by Ube2S and APC/C and sensitive to TEV cleavage. Ub-cyclin AHA was incubated with APC/C, Ube2S, and WT-ubiquitin or ubiTEV
mutants. Reactions were treated with TEV and analyzed by aHA-western blot.
(C) 35S-cyclin A was incubated with APC/C, Ube2C, and Ube2S and ubiquitin, ubiTEV, or ubiTEV/FLAG proteins. Reactions were treated with TEV and analyzed by
autoradiography.
(D) Ub-cyclin A or Ub-Nek2A272-445 was incubated with APC/C, Ube2S, ubi53TEV, and ubi64TEV/FLAG to add unbranched K11-linked chains; alternatively, cyclin A or
Nek2A was modified by APC/C, Ube2C, Ube2S, ubi53TEV, and ubi64TEV/FLAG with branched chains. Reactions were treated with TEV and analyzed by aFLAG-
western.
(E) Nek2A272-445 was incubated with APC/C, Ube2C, Ube2S, ubi53TEV, and ubi64TEV/FLAG. APC/Cwas purified fromG1 phase, when it was active, or S phase, when
APC/C-activity was low. APC/C was also inhibited by Emi1. Reactions were treated with TEV and analyzed by aFLAG-western.
(F) APC/C was purified from prometaphase HeLa cells transfected with control or Ube2S siRNA and analyzed for copurifying K11-linked chains using aK11-
western.
(G) APC/C synthesizes branched chains in vivo. APC/C was purified from asynchronous cells expressing FLAGubi53TEV and Hisubi64TEV/FLAG, treated with TEV, and
analyzed by aFLAG-western. Top: conjugates copurifying with APC/C. Bottom: MW range for diagnostic peptides (longer exposure). Ubiquitin detected in
reactions without TEV is produced by DUBs that coprecipitate with APC/C.
(H) APC/C was purified from cells WT- or Lys mutant FLAGubi53TEV and HISubi64TEV/FLAG, treated with TEV, and analyzed for copurifying conjugates (top) or
diagnostic peptides (bottom).
(I) Nek2A is modified with branched chains in cells. HANek2A was purified from cells expressing FLAGubi53TEV and Hisubi64TEV/FLAG and treated with TEV. Reactions
were analyzed by aFLAG-western blot.
See also Figure S3.Importantly, diagnostic branched peptides were observed on
Nek2A and cyclin A, further demonstrating that APC/C, Ube2C,
and Ube2S modify substrates with branched chains (Figure 3D).
By contrast, no branches were detected if we incubated Ub-914 Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc.cyclin A or Ub3-Nek2A with APC/C and Ube2S, leading to the
attachment of unbranched K11-linked chains (Figure 3D). More-
over, branched conjugates were absent if Nek2A was incubated
with ubiR11/48/63, a mutant that inhibits the formation of linkages
used by Ube2C and Ube2S, if the APC/C was purified from S
phase cells, when it is inactive, or if active APC/C was inhibited
by Emi1 (Figures 3E and S3F).
To determine whether the APC/C synthesizes branched
chains in cells, we built on the observation that mitotic APC/C
copurifies with proteins modified with K11-linked chains. Forma-
tion of these conjugates was dependent on Ube2S (Figure 3F),
and they were eliminated by treatment with the K11-specific
DUB Cezanne (Figure S3C). The K11-linked chains could be
washed off the APC/C with high-salt buffers (Figure S3D), indi-
cating that they were attached to endogenous substrates that
remained bound to the APC/C following their modification.
Therefore, we expressed FLAGubi53TEV and ubi64TEV/FLAG under
conditions that did not change ubiquitin levels (Figure S3E), pu-
rified the APC/C with coprecipitating substrates, and treated the
samples with TEV. These experiments showed that endogenous
APC/C substrates were modified with branched chains, with the
branching pattern reflecting that of our in vitro analyses (Fig-
ure 3G). The formation of branched linkages was severely
reduced upon expression of ubiR11/48/63, a mutant that obliter-
ated branching in vitro, or upon synchronization of cells in S
phase, when APC/C is inactive (Figures 3H and S3G). To test
whether the APC/C modifies a specific substrate with branched
chains, we purified ubiquitylated Nek2A from cells expressing
ubiTEV constructs. Treatment of Nek2A purifications with TEV
revealed a high fraction of branched chains, similar to the modi-
fication of Nek2A with such conjugates in vitro (Figure 3I). These
findings were supported by the observation that expression of
ubiK6/11, a mutant that allows formation of K11-linked chains
but prevents branched conjugates, strongly impaired the modi-
fication of APC/C substrates in cells (Figure S3H). We conclude
that the APC/C assembles branched chains in cells, with Nek2A
being an efficient substrate for this modification.
Altering the Linkage Specificity of Metazoan APC/C
To determine specific functions of branched chains, we required
an experimental system that allowed us to compare the fate of a
substrate decorated with different homogenous chains or
branched conjugates that resulted from a combination of the
previous chain types, respectively. Such experiments are diffi-
cult to perform with Ube2C, as this E2 produces chains of mixed
topology and length. To overcome this limitation, we engineered
a K48-specific APC/C-E2 that, together with the physiological
E2s, enabled us to modify substrates with K11-linked, K48-
linked, or K11/K48-branched chains.
To generate a K48-specific APC/C-E2, we focused on the
C-terminal peptide (CTP) of Ube2S: whereas deletion of the
CTP abrogated binding of Ube2S to the APC/C, its fusion was
sufficient to deliver a heterologous protein to the APC/C (Figures
S4A–S4E). If we appended the CTP to the K48-specific
E2 Ube2G2, the resulting Ube2G2CTP bound the APC/C (Figures
S4F andS4G) and ubiquitylated substrates with similar efficiency
as Ube2S (Figures 4A and S4H). The activity of Ube2G2CTP
toward the APC/C was inhibited by mutation of its active site
(Figures S4I and S4J), addition of pseudosubstrate or competi-
tive APC/C-inhibitors (Figure 4B), or mutation of APC/C-degrons
in substrates (Figure 4C). Importantly, assays with ubiquitin
mutants or linkage-specific antibodies demonstrated thatUbe2G2CTP modified APC/C substrates with K48-linked chains
(Figures 4D–4F).
To test whether we could use the engineered E2 to produce
branched chains, we incubated Ub-cyclin A with APC/C,
Ube2G2CTP, and ubiquitin under conditions that led to attach-
ment of two K48-linked ubiquitin molecules (Ub3-cyclin A). We
then inactivated Ube2G2CTP by an excess of ubiR48 before we
added Ube2S. As expected for the assembly of branched
chains, Ube2S decorated Ub3-cyclin A with conjugates of
much higher MW than those formed on Ub-cyclin A, a substrate
that can only be modified with a single K11-linked chain (Fig-
ure 4G). Similar high MW conjugates were detected in single-
substrate turnover assays that contained Ube2G2CTP and
Ube2S at the same time but were absent if only one E2 was
used or the active site of Ube2G2CTP was mutated (Figure 4H).
High MW chains were also seen in extracts and cells, if both
Ube2S and Ube2G2CTP were present (Figures S5A and S5B).
Sequential purification of these conjugates or treatment with
the K11-specific DUB Cezanne revealed that they contained
K11 and K48 linkages (Figures S5C and S5D). Importantly,
Ube2S and Ube2G2CTP did not produce high MW chains if incu-
bated with mixtures of ubiR11 and ubiR48 (Figure 4I). Under these
conditions, mixed chains with K11 and K48 linkages can be syn-
thesized, but—as no ubiquitin contains K11 and K48 at the same
time—K11/K48-branched chains cannot be produced. Thus,
these experiments show that Ube2S and Ube2G2CTP efficiently
produce K11/K48-branched chains on APC/C substrates.
Branched Chains Are Stronger Proteolytic Signals
To determine the functional consequences of branched chains,
we depleted Ube2S from cells to prevent the formation of such
conjugates under physiological conditions. However, as loss of
Ube2S also interferes with chain elongation, we used the physi-
ological and engineered APC/C-E2s as a complementary
approach to modify substrates with distinct chain types in vitro
or to increase branched chain formation in cells. The combina-
tion of both strategies should allow us to pinpoint important roles
of branched ubiquitin chains in vitro and in cells.
We first tested how modification with distinct chains affects
substrate recognition by effectors, such as the proteasome or
p97. Intriguingly, whereas substrates modified with either K11-
or K48-linked chains were similarly recognized by receptors of
the proteasome or p97 (Figure 5A; Figures S6A–S6C), the
same proteins decorated with K11/K48-branched chains asso-
ciated with these effectors much more efficiently (Figures 5B,
5C, and S6D). The preferential recognition of branched chains
was best seen in reactions that compared homogenous and
branched conjugates at the same time (Figures 5B and S6D),
and it was not a mere function of the number of ubiquitin mole-
cules, as the proteasomal receptor S5A recognized branched
chains more efficiently than K48-linked chains of equal MW (Fig-
ure 5C). Similar effects were seen for physiological APC/C-E2s,
which targeted Nek2A more efficiently to S5A by modifying it
with branched, rather than homogenous, chains (Figure 5D). As
expected from these results, branched chains were more effi-
cient thanwere linear K11-linked conjugates in driving the degra-
dation of Nek2A by purified proteasomes (Figure 5E). In contrast,
the DUBs Cezanne or Usp37 similarly processed homogenousCell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc. 915
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Figure 4. Synthesis of Branched Chains with Defined Composition
(A) 35S-cyclin A was incubated with APC/CCdh1 and no E2, Ube2G2, or Ube2G2CTP. Reactions were analyzed by autoradiography.
(B) 35S-labeled cyclin A was incubated with APC/CCdh1, low levels of Ube2C, and Ube2G2CTP or Ube2S. APC/C was inhibited by Emi1 or an excess of
recombinant APC/C substrate. Reactions were analyzed by autoradiography.
(C) 35S-geminin or mutants in its D-box or initiation motif (IM) were incubated with APC/C, low levels of Ube2C, and Ube2G2CTP or Ube2S. Reactions were
analyzed by autoradiography.
(D) Ube2G2CTP catalyzes chain formation with ubiK48. 35S-cyclin A was incubated with APC/C, low levels of Ube2C, Ube2S or Ube2G2CTP, and ubiquitin mutants.
Reactions were analyzed by autoradiography.
(E) Ube2G2CTP requires K48 of ubiquitin for chain formation. 35S-cyclin A was incubated with APC/C, low levels of Ube2C, Ube2S or Ube2G2CTP, and ubiquitin
variants. Reactions were analyzed by autoradiography.
(F) Ube2G2CTP catalyzes K48-linked chain formation with APC/C. Ub-cyclin A was incubated with APC/C, either Ube2S or Ube2G2CTP, and ubiquitin. Reaction
products were analyzed by western blot.
(G) Ube2S and Ube2G2CTP synthesize high MW conjugates. Ub-cyclin A was mixed with Ube2G2CTP and low levels of ubiquitin, leading to the addition of two
K48-linked ubiquitin molecules (Ub3-cyclin A). Next, an excess of ubi
R48 and Ube2S were added. Ub-cyclin A was also directly incubated with Ube2S and ubiR48.
Reactions were analyzed by western blot.
(H) High MW chains are seen in single-substrate turnover assays. An excess of Ub-cyclin A (1 mM) over APC/CCdh1 (10 nM) was incubated with Ube2S, Ube2S/
Ube2G2CTP, or Ube2S and Ube2G2CTP-C89S. Reactions were analyzed by western blot.
(I) High MW conjugates assembled by Ube2S and Ube2G2CTP are branched chains. Ub-cyclin A was incubated with APC/C, Ube2S, Ube2G2CTP, and ubiquitin
mutants under single-substrate turnover conditions and analyzed bywestern blot. Mixtures of ubiR11 and ubiR48 allowUbe2S andUbe2G2CTP to synthesizemixed
chains yet prevent introduction of branches.
See also Figures S4 and S5.
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Figure 5. Branched Chains Enhance Pro-
teasomal Degradation
(A) Ub-cyclin A was modified by the APC/C and
Ube2S or Ube2G2CTP with either K11- or K48-
linked chains. Reaction products were incubated
with immobilized MBPS5a either alone or together
and analyzed by western blot.
(B) Proteins decorated with K11/K48-linked
branched chains bind more efficiently to S5a than
those modified with single chains. Ub-cyclin A
modified with K11-linked or K11/K48-branched
chains were incubated with MBPS5a under strin-
gent conditions, and binding was monitored by
western blot.
(C) Preferential binding of branched chains is
independent of chain length. 35S-labeled cyclin A
was modified by APC/C, low levels of Ube2C,
Ube2S and/or Ube2G2CTP, and ubiquitin, ubiK11,
or ubiK48 to assemble K11-linked, K48-linked,
or K11/K48-branched chains and incubated
with S5a.
(D) Branched chains increase the affinity of Nek2A
for the proteasomal receptor S5a. 35S-labeled
Nek2A272-445 was modified by APC/C, Ube2C,
and Ube2S with homogenous or branched chains
(using ubiK11 or wild-type ubiquitin) and incubated
with MBPS5a. Reactions were analyzed by auto-
radiography.
(E) Branched chains improve the efficiency
of proteasomal degradation in vitro. 35S-HA-
Nek2A272-445 was modified with branched or
homogenous K11-linked chains and added to
increasing concentrations of 26S proteasomes. Five independent titrations were monitored by autoradiography and quantified using ImageJ (n = 5; data are
average ± SD; **p < 0.002 in paired t test; ***p < 0.001). The asterisk marks background degradation by proteasomes that copurify with APC/C.
(F) Branched chains promote degradation more efficiently. Prometaphase extracts with endogenous Ube2S were treated with Ube2G2CTP in the presence of
ubiquitin mutants. The stability of geminin wasmonitored bywestern blot. Geminin was stable in extracts containingmixtures of ubiR11 and ubiR48, a condition that
allows Ube2S and Ube2G2CTP to assemble mixed, but not branched, chains.
See also Figure S6.or branched linkages (Figures S6E and S6F), showing that
branched chains do not improve substrate recognition by all ef-
fectors of ubiquitin-dependent signaling.
We next compared the distinct chain types in extracts, a sys-
tem that had allowed the discovery of K11-linked chains and
Ube2S (Jin et al., 2008; Williamson et al., 2009). Extracts that
either contained K11- or K48-specific APC/C-E2 supported the
degradation of anaphase substrates with comparable efficiency
(Figures S6G and S6H). However, neither E2 by itself was able to
promote degradation of a substrate with low affinity for the APC/
C or trigger substrate turnover under conditions of low APC/C
activity (Figures 5F and S6I). In contrast, combination of K11-
and K48-specific APC/C-E2s rapidly induced degradation even
under challenging conditions (Figures 5F and S6I). As this was
not observed with mixtures of ubiR11 and ubiR48, the improved
proteolytic capacity of combined APC/C-E2s required the for-
mation of branched chains.
To analyze signaling by branched chains in vivo, we compared
stable cell lines that expressed Ube2S to produce K11-linked
chains, Ube2G2CTP and siRNAs against Ube2S to synthesize
K48-linked chains, or both K11- and K48-specific APC/C-E2s
to assemble K11/K48-branched chains. To exclude overexpres-
sion artifacts, we selected cells that expressed less Ube2G2CTPthan endogenous Ube2S, and we generated cell lines that con-
tained an extra copy of Ube2S as controls. Confirming our
in vitro analyses, either K11- or K48-specific E2 promoted sub-
strate degradation during anaphase, a time of high APC/C activ-
ity (Figures S7A–S7C). Still, branched chains appeared to be
stronger signals: in normal cells, ubiquitylated substrates remain
temporarily bound to the APC/C. By contrast, in cells assembling
K11/K48-branched chains, in addition to the physiological-
branched conjugates, such proteins were only detected on the
APC/C if the proteasome was inhibited, suggesting that an
increased formation of branched chains facilitated substrate
extraction from APC/C and degradation by the proteasome (Fig-
ure 6A). Accordingly, the levels of a model substrate were
reduced upon coexpression of endogenous Ube2S and
Ube2G2CTP (Figure S7D). For Nek2A, the same results were ob-
tained with physiological E2s: under conditions that supported
formation of branched chains, Nek2A was rapidly extracted
from the APC/C in a proteasome-dependent manner (Figures
6B and 6C). By contrast, if Ube2S was depleted and formation
of branched chains was inhibited, Nek2A remained bound to
the APC/C (Figure 6B), coinciding with its stabilization and
hyperphosphorylation of an APC/C subunit (Figures 1B and Fig-
ures 6B–6D).Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc. 917
Figure 6. Branched Chains Promote Proteasomal Degradation in Cells
(A) Branched chains facilitate extraction of ubiquitylated substrates from the APC/C. HeLa cells stably expressing Ube2G2CTP and endogenous Ube2S were
released from nocodazole-induced mitotic arrest and treated with proteasome inhibitor MG132, as indicated. Copurifying K11-conjugates were monitored by
western blot.
(B) Branched chains facilitate extraction of Nek2A from the APC/C. HeLa cells transfected with control or Ube2S siRNA were synchronized in prometaphase and
treated with cycloheximide. APC/C was purified at indicated times after cycloheximide addition, and copurifying proteins were analyzed by western blot.
(C) The stability of Nek2A-binding to the APC/C was analyzed in prometaphase HeLa cells treated with cycloheximide and proteasome inhibitors.
(D) APC/C was purified from prometaphase HeLa cells treated with control or Ube2S siRNA, and levels of copurifying proteins were determined by western blot.
(E) Stable expression of Ube2G2CTP, but not Ube2G2CTP-C89S, causes spindle checkpoint bypass. Top: HeLa cells stably expressing the indicated proteins were
treatedwith taxol. Mitotic arrest was scored by automatedmicroscopy (n = 3; >1,000 cells/condition; data are average ±SD; unpaired t tests p < 0.0005). Bottom:
images of representative cells stained with Hoechst.
(F) Checkpoint bypass requires Ube2G2CTP and Ube2C/Ube2S. HeLa cells or stable cell lines expressing Ube2G2CTP were treated with siRNAs against Ube2C
and Ube2S, as well as taxol, and the mitotic index was determined by automated microscopy (n = 3; 1,000 cells/condition; data are average ± SD; paired t test
p < 0.02).
See also Figure S7.Consistent with these observations, constitutive formation of
K11/K48-branched chains resulted in spindle checkpoint
bypass and aneuploidy, known consequences of increased
APC/C-activity (Figures 6E and S7E). These phenotypes were
observed most strongly at equimolar levels of Ube2G2CTP and
Ube2S (Figure S7F) and hence at conditions of most efficient
branching, but they were observed much less dramatically if
either K11- or K48-specific E2 was absent (Figure 6F) or if an ex-
tra copy of Ube2S was expressed (Figure S7G). These findings
corroborated our Ube2S depletion studies: asmentioned before,
loss of Ube2S and concomitant inhibition of branched chain for-
mation impeded Cdc20 ubiquitylation, the reaction that drives918 Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc.checkpoint disassembly (Figure 1C); sensitized cells to nocoda-
zole (Figure S1F); and blocked the release of cells from a spindle
checkpoint-dependent arrest (Figure 1D). These experiments,
therefore, support the notion that the formation of branched
chains increases the proteolytic capacity of the APC/C, allowing
it to efficiently degrade its prometaphase substrates.
DISCUSSION
In this study, we identified the APC/C as an enzyme that synthe-
sizes branched ubiquitin chains and discovered a critical role for
such conjugates in driving efficient proteasomal degradation.
Figure 7. Enhanced Protein Degradation by Branched Ubiquitin
Chains
APC/C substrates are initially modified by Ube2C with short chains containing
K11, K48, and K63 linkages. Ube2S adds blocks of 6 K11-linked ubiquitin
molecules to each chain moiety with an unmodified K11. This process leads to
the formation of branched ubiquitin chains that increase the proteolytic
capacity of the initial ubiquitylation mark.Branched conjugates are synthesized during mitosis when
Ube2S adds multiple K11-linked chains to mixed assemblies
produced by the initiating E2s of APC/C (Figure 7). Branched
chains strongly improve proteasomal substrate recognition,
and accordingly, they are required for degradation at times of
limited APC/C activity. We have observed similar branching
activities for K48- and K63-specific enzymes (data not shown),
suggesting that branched chains might frequently be employed
in ubiquitin-dependent signaling.
How Are Branched Ubiquitin Chains Synthesized?
The assembly of branched chains depends on the cooperation
of ubiquitylation enzymes with different linkage specificities, a
condition fulfilled by the E2s of metazoan APC/C. Ube2C initi-
ates chain formation by modifying substrates with short conju-
gates containing 50% K11 linkages, but also K48 and K63
linkages (Kirkpatrick et al., 2006). At least in vitro, the APC/C
is also able to nucleate chains with E2s of the Ube2D family,
which synthesize ubiquitin chains with little linkage preference
(Kirkpatrick et al., 2006). If the initiating E2s use K48 or K63
linkages, K11 of an internal ubiquitin remains unmodified and
provides a site for Ube2S to branch off a K11-linked chain.
Ube2S is also able to modify ubiquitin molecules embedded
in linear or completely K48-linked chains. This indicates that
the presence of a free K11, but not of an overall chain linkage
or structure, determines formation of a branch point. Consistent
with this notion, Ube2S synthesized a branch with the same
efficiency and specificity as it promoted chain elongation at
the distal ubiquitin.
It is interesting to note that Ube2S synthesizes a branched
linkage with such high efficiency. As documented with linkage-
specific antibodies, the accumulation of K11-linked chains
during mitosis depends entirely on Ube2S (Matsumoto et al.,
2010; Wickliffe et al., 2011), indicating that its linkage specificity
is different from most, if not all, mitotic ubiquitylation enzymes.
Combined with its efficiency in synthesizing branched linkages,
this observation implies that Ube2S could also branch K11-
linked chains off conjugates initiated by other enzymes that
interact with the APC/C. If this were the case, our findings raise
the interesting possibility that the K11-specificity of metazoan
APC/C did not arise because of a particular function of this
topology, but because it allowed the formation of branched
chains on as many initial conjugates as possible.What Is the Signaling Function of Branched Ubiquitin
Chains?
To decipher the information encoded by branched chains, we
generated a toolkit of E2s that allowed us to modify substrates
with K11-linked, K48-linked, or K11/K48-branched chains. A
key result of these studies, we could show for the same protein
that K11- and K48-linked chains mediate substrate binding to
the proteasome with similar efficiency, and accordingly, both
chain topologies trigger degradation at times at which the
APC/C is fully active. These findings confirm that K11-linked
chains are powerful degradation signals (Jin et al., 2008; Matsu-
moto et al., 2010). Moreover, they show that the K11 specificity
of the APC/C is not essential for the turnover of anaphase sub-
strates, whereas K48-linked chains are not a prerequisite for
substrate targeting to the proteasome. Our observations thus
support studies that found most linkages to accumulate in
response to proteasome inhibition, indicative of a proteolytic
role for the majority of chain topologies (Dammer et al., 2011;
Peng et al., 2003; Xu et al., 2009).
Providing a potential explanation for this apparent redun-
dancy, we propose that the combination of different chain types
allows formation of branched conjugates with improved
signaling capacity. Branched conjugates with multiple blocks
of K11-linked chains, as generated by the APC/C, increased
the efficiency of substrate recognition by the proteasome,
and, accordingly, promoted degradation in purified systems,
extracts, or cells even under conditions of low APC/C activity.
Thus, distinct from randomly branched chains that impair degra-
dation (Kim et al., 2007), the branched conjugates assembled by
the APC/C act as particularly powerful proteolytic signals.
Why branched chains with multiple blocks of K11-linkages
facilitate proteasomal degradation requires further analysis. We
favor the idea that the higher signal capacity of branched chains
originates from increased levels of substrate-attached ubiquitin,
which overcome themodest affinity of effectors toward ubiquitin.
As longer ubiquitin chains do not provide a similar effect (Fig-
ure 5C; Thrower et al., 2000), it is likely that ubiquitin has to be
concentrated close to the substrate, thus promoting multivalent
recognition by effectors with several ubiquitin-binding domains
in the same complex. Indeed, the proteasome and p97, both of
which efficiently bind branched chains, contain multiple binding
domains for ubiquitylated substrates (Finley, 2009; Lander
et al., 2012; Richly et al., 2005). If this hypothesis were correct,
we expect that multiple short chains attached to neighboring
substrate lysines should also stimulate degradation. However,
few substrates have clusters of Lys residues allowing the
formation of such structures. Moreover, attachment of the first
ubiquitin to a substrate Lys is often the rate-limiting step of chain
formation (Pierce et al., 2009; Williamson et al., 2011), and cleav-
age of the proximal ubiquitin represents the rate-limiting step of
degradation (Finley, 2009). The capacity of branched chains to
increase the ubiquitin density without introducing more rate-
limiting steps could provide an explanation for why these conju-
gates generate a particularly powerful proteolytic signal.
Evolutionary Implications of Branched Chain Formation
Our discovery that human APC/C assembles branched chains
might provide insight into the changes in linkage specificityCell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc. 919
that occurred between yeast and metazoan APC/C. As yeast
APC/C initiates chain formation with Ubc4/5, a set of E2s that
add single ubiquitin molecules to substrates (Rodrigo-Brenni
and Morgan, 2007), it is unlikely to support branching. Metazoan
APC/C synthesizes branched chains with Ube2C and Ube2S,
two E2s that are not present in yeast. In this study, we found
that Ube2S plays an important role in prometaphase, a cell-cycle
stage that is different in yeast, which undergoes closed mitosis,
and metazoans, where nuclear envelope breakdown dictates
that spindle assembly occurs without the chromosomes being
confined to a subcellular compartment. Possibly reflecting these
differences, few substrates are degraded during prometaphase
in yeast, whereas in metazoans several examples of APC/C sub-
strate degradation have been reported at this cell-cycle time
(Amador et al., 2007; Hayes et al., 2006; Sedgwick et al., 2013;
Song and Rape, 2010; Wolthuis et al., 2008). In addition, prom-
etaphase APC/C continuously disassembles spindle checkpoint
complexes, resulting in a dynamic interplay between the APC/C
and the checkpoint. Checkpoint disassembly is strongly pro-
moted by a metazoan-specific protein, p31comet, which might
point to an increased extent of checkpoint disassembly in these
organisms (Foster and Morgan, 2012; Reddy et al., 2007; Uzu-
nova et al., 2012; Varetti et al., 2011; Williamson et al., 2009).
We therefore speculate that the increased proteolytic capacity
of branched chains, formation of which required the emergence
of Ube2C and Ube2S, allowed themetazoan APC/C to copewith
higher demands on its activity during early stages of cell division.EXPERIMENTAL PROCEDURES
An extended version can be found in the Extended Experimental Procedures.
Plasmids
Ube2G2CTP was generated by fusing human Ube2G2 to residues 186–222 of
Ube2S. To produce Ub-Ub-cyclin A, ubiquitin1-74 was fused to Ub-cyclin A
with a GSEDLYFQSG linker. To generate Ub3-cyclin A or Ub3-Nek2A
272-445,
a 3x ubiquitin DNA template was synthesized and fused to the substrate.
TEV ubiquitin derivatives were created by inserting a TEV site after G53
(SENLYFQGS), E64 (NLYFQG), or L71 (GSENLYFQGS). A FLAG-epitope
was added after E64 to create TEV/FLAG. Mutagenesis to create K11R,
K48R, and K63R mutations was performed as described.
APC/C Ubiquitylation
35S-labeled substrates were synthesized by in vitro transcription/translation.
APC/C was purified fromG1-HeLa cells, and endogenous Ube2Swas washed
off by 500mMNaCl and 0.1%Triton. Beads were incubated for 30minwith E1,
60 mM ubiquitin, 3 mM ATP, 22.5 mM creatine phosphate, 1 mM DTT, and
substrate. The concentrations of Ube2S, Ube2G2, and Ube2G2CTP were
10 mM, of Ube2C in combination with Ube2S or Ube2G2CTP 100 nM, and of
Ube2C by itself 10 mM.
Branched Chain Detection
To detect branched linkages on Nek2A, 5 mM HisNek2A272-445 was incubated
with APC/C, 100 nM E1, 3 mM ATP, 22.5 mM creatine phosphate, 1 mM
DTT, 10 mM Ube2C, 10 mM Ube2S, 60 mM ubiTEV, and 60 mM ubiTEV/Flag for
30 min at 37C. TEV was added for 1 hr at 34C. Reactions were resolved
by 20% Tricine SDS-PAGE. To detect branched linkages in vivo, Flagubi53TEV
and Hisubi64TEV/Flag were expressed in 293T cells. After 48 hr, lysates were
subjected to immunoprecipitation by aCdc27- or aHA-antibody. After washes,
TEV was added for 1 hr at 34C. Reactions were resolved by 20% Tricine
SDS-PAGE.920 Cell 157, 910–921, May 8, 2014 ª2014 Elsevier Inc.Purification of Endogenous Ubiquitin Conjugates
To purify ubiquitylated proteins, eight 15 cm dishes of HeLa cells were
transfected with 5 nM control or Ube2S siRNA (Lipofectamine RNAimax;
Invitrogen). After 18 hr, cells were also transfected with Hisubiquitin. After
21 hr, cells were treated with 100 ng/ml nocodazole for 16 hr and 15 mM
MG132 for the last 2 hr of synchronization. Cells were resuspended in 8 M
Urea and lysed by sonication. Hisubiquitin-conjugates were purified under
denaturing conditions on NiNTA agarose and detected by western blot.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.03.037.
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